We are live on ! Find out more
ACA

Atlas Capital Advisors Portfolio holdings

AUM $875M
This Fund
S&P 500
This Quarter Est. Return
-13.14%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$590M
AUM Growth
-$53.8M
Cap. Flow
+$45.6M
Cap. Flow %
7.73%
Top 10 Hldgs %
26.41%
Holding
1,042
New
133
Increased
224
Reduced
244
Closed
71

Sector Composition

Rank Sector Weight
1 Technology 10.93%
2 Consumer Staples 8.92%
3 Healthcare 5.53%
4 Financials 4.77%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADVM
926
DELISTED
Adverum Biotechnologies
ADVM
-425
Closed -$5.57K
ARGX icon
927
argenx
ARGX
$54.1B
-180
Closed -$56.8K
ARWR icon
928
Arrowhead Research
ARWR
$12.4B
-220
Closed -$10.1K
BB icon
929
BlackBerry
BB
$5.26B
-6,181
Closed -$46.1K
BBHY icon
930
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$618M
-15,700
Closed -$768K
BKLN icon
931
Invesco Senior Loan ETF
BKLN
$6.81B
-28,100
Closed -$612K
BNS icon
932
Scotiabank
BNS
$108B
-484
Closed -$34.7K
BPMC
933
DELISTED
Blueprint Medicines
BPMC
-170
Closed -$10.9K
CAH icon
934
Cardinal Health
CAH
$55.4B
-399
Closed -$22.6K
CLDX icon
935
Celldex Therapeutics
CLDX
$3.28B
-2,700
Closed -$92K
CM icon
936
Canadian Imperial Bank of Commerce
CM
$108B
-2,070
Closed -$126K
CMF icon
937
iShares California Muni Bond ETF
CMF
$4.62B
-36,405
Closed -$2.12M
EMB icon
938
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
-5,050
Closed -$494K
EVRI
939
DELISTED
Everi Holdings
EVRI
-1,636
Closed -$34.4K
FALN icon
940
iShares Fallen Angels USD Bond ETF
FALN
$1.62B
-16,788
Closed -$466K
FDMT icon
941
4D Molecular Therapeutics
FDMT
$562M
-675
Closed -$10.2K
FFIV icon
942
F5
FFIV
$22.7B
-131
Closed -$27.4K
FRO icon
943
Frontline
FRO
$8.85B
-119
Closed -$1.05K
GIL icon
944
Gildan
GIL
$10.6B
-1,790
Closed -$67.1K
LKFT
945
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
-348
Closed -$21.6K
GMAB icon
946
Genmab
GMAB
$19.5B
-900
Closed -$32.6K
HBAN icon
947
Huntington Bancshares
HBAN
$35.5B
-15,883
Closed -$232K
IBIO icon
948
iBio
IBIO
$70M
-1
Closed -$214
ING icon
949
ING
ING
$102B
-15,495
Closed -$162K
IOVA icon
950
Iovance Biotherapeutics
IOVA
$2.87B
-950
Closed -$15.8K

Similar funds

Atlas Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Atlas Capital Advisors held 1,042 positions worth $590M, down 8.4% from $644M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Atlas Capital Advisors deployed $45.6M of net new capital in Q2 2022, opening 133 new positions and adding to 224 existing holdings. Its largest new stake was iShares Core Conservative Allocation ETF: 518,500 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $10.3M trimmed.

  • Atlas Capital Advisors's largest Q2 2022 buy was iShares Core Conservative Allocation ETF: 518,500 shares worth $17.9M.
  • Atlas Capital Advisors added most to Procter & Gamble in Q2 2022, an estimated $28.5M increase.
  • Atlas Capital Advisors's biggest Q2 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $10.3M.
  • Atlas Capital Advisors fully exited iShares California Muni Bond ETF in Q2 2022, selling an estimated $2.12M.
  • Atlas Capital Advisors's ten largest holdings make up 26% of its $590M portfolio in Q2 2022.
  • Atlas Capital Advisors opened 133 new positions and closed 71 in Q2 2022.
  • Atlas Capital Advisors's portfolio value fell 8.4% quarter-over-quarter to $590M.

Based on Atlas Capital Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.